Michael D. Krepps
Chief Operating Officer
Mike leads all strategic and operational efforts for OncoPep. He also serves as an EIR with Cobro Ventures. Prior to joining OncoPep as COO, Mike worked as a scientist, consultant, entrepreneur, and VC.
Mike’s most recent role was with the American Cancer Society’s VC fund (BrightEdge). In this role, he led the investment team, managed diligence efforts of all potential investment opportunities, and sat on the Investment Committee. During this time, Mike held Board Observer roles at Navigating Cancer, Tmunity, Freenome, and Interius. Prior to joining BrightEdge, Mike worked as an Associate Principal in the Life Sciences Practice of the CRA consulting group where he led global engagements in therapeutic area strategy, asset strategy, pipeline optimization, pricing & market access, M&A, and corporate strategy, primarily in oncology and immunology.
Mike was originally trained as a scientist, and his scientific experience includes co-founding SynActive Biosciences, a startup focused on stem cell-derived neuron technologies, and working as a Program Manager/Senior Scientist in the Biosciences Division at the Department of Defense. At the Department of Defense, Mike researched immunology and infectious disease with a focus on emerging pathogens and bio-terrorism threat agents. Additionally, he has authored many publications and has presented his research at leading academic conferences.
Mike received a Master of Science in genetics and a Bachelor of Science in bacteriology from the University of Wisconsin-Madison and an MBA in finance, strategy, and entrepreneurship from the University of Chicago Booth School of Business. He is conversant in German and Spanish.